In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Galen buys Warner Chilcott in all stock deal

Executive Summary

Galen is buying fellow UK pharma company Warner Chilcott in an all-stock transaction that values Warner at $406mm on a fully diluted basis. Warner Chilcott shareholders will get 2.5 Galen shares for each Warner American Depository Share, which trade on Nasdaq. Galen shares currently trade of the London Stock Exchange but the after the merger it will file to trade on Nasdaq also.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies